These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3670749)

  • 21. Atrophy of the striatum and motor disturbance induced by colchicine.
    Kamata K; Okuyama S; Hashimoto S; Kumura MA; Aihara H; Kasuya Y
    Brain Res; 1987 Sep; 421(1-2):353-7. PubMed ID: 3690277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage.
    Fornai F; Battaglia G; Gesi M; Orzi F; Nicoletti F; Ruggieri S
    Brain Res; 2001 Apr; 898(1):27-35. PubMed ID: 11292446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
    Brown EE; Damsma G; Cumming P; Fibiger HC
    J Neurochem; 1991 Aug; 57(2):701-7. PubMed ID: 1906527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dopaminergic mechanism mediates the d-amphetamine- and apomorphine-induced increase of ascorbic acid metabolism in the rat striatum.
    Miele M; Desole MS; Enrico P; Esposito G; De Natale G; Miele E
    Pharmacol Res; 1990; 22 Suppl 3():41-2. PubMed ID: 2097636
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
    Wuerthele SM; Friedle NM; Moore KE
    J Neural Transm; 1979; 45(2):117-27. PubMed ID: 469523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations into the relationship between the dopaminergic system and ascorbic acid in rat striatum.
    Desole MS; Miele M; Enrico P; Esposito G; Fresu L; De Natale G; Miele E
    Neurosci Lett; 1991 Jun; 127(1):34-8. PubMed ID: 1881615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effect of apomorphine and haloperidol on MPP neurotoxicity.
    Espinosa-Oliva AM; de Pablos RM; Santiago M
    Pharmacology; 2014; 93(3-4):101-7. PubMed ID: 24556705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endovenous dopamine after cessation of impulse flow.
    Walters JR; Roth RH
    Biochem Pharmacol; 1976 Mar; 25(6):649-54. PubMed ID: 6034
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
    Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
    Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL; Grewaal DS; McGeer EG
    Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.